by Heather Galipeau
A new study published in Science by Bouziat and colleagues show that reovirus, which are mild or clinically silent viruses that infect humans frequently over the course of a lifetime, can break tolerance to dietary proteins and may constitute an environmental modifier for CeD development.
by GMFH Editing Team
After the intensive weekend of knowledge sharing about gut microbiota and health from scientific experts from all over the world, the Gut Microbiota for Health team is happy to bring you the replay of the plenary sessions.
by Andreu Prados
A recent study led by Dr. Jun Sun (Department of Medicine, University of Illinois, Chicago, USA) has found that butyrate, a bacterial metabolic by-product, may normalize the intestinal environment.
by Andreu Prados
A recent review, led by Dr. Hai Lu from the Department of Orthopedic Surgery at The Third Affiliated Hospital of Southern Medical University in Guangzhou (China), discusses the existing evidence for the role of gut microbiota in ankylosing spondylitis.
by Andreu Prados
Now a recent study, led by Dr. Nicola Santoro from the Department of Paediatrics at Yale University in New Haven, Connecticut (USA), has found that the gut microbiota of obese youth may drive a higher accumulation of energy than that of lean adolescents through an elevated production of short-chain fatty acids (SCFAs) and a higher capability to oxidize carbohydrates.
At the Gut Microbiota for Health World Summit 2016 that was held in Miami (USA) March 5-6, 2016, leading experts presented up-to-date evidence on clinical applications of gut microbiota and its mechanisms and role in human health and disease.
by Paul Enck
A recent study, led by Vanessa Stadlbauer from the Department of Gastroenterology and Hepatology, Medical University of Graz, in Graz (Austria), has found that a multispecies probiotic may have beneficial effects on immune function in patients with cirrhosis.
by Andreu Prados
A recent study, led by Prof. Andrew J. Dannenberg from the Department of Medicine at Weill Cornell Medical College at Cornell University in New York, has found that the chemopreventive activity of the drug celecoxib can be explained in part by its effects on the gut microbiota and its metabolites.
by GMFH Editing Team
Bernd Schnabl is an Associate Professor in Gastroenterology at University of California San Diego School of Medicine, where he investigates precisely the pathogenesis of chronic liver disease. He attended the 5th Gut Microbiota for Health World Summit 2016.
by Andreu Prados
A recent study, led by Dr. Oluf Pedersen from the Faculty of Health and Medical Sciences at University of Copenhagen in Denmark, has found that dysbiosis of the human gut microbiota impacts the serum metabolome and contributes to the state of IR and metabolic syndrome.
